Skip to main content

Moderna’s first-ever profit and billion-dollar quarter is dampened by COVID-19 vaccine patent proposal

It's been a complicated day for Moderna Inc. as the company reported its first-ever profit and its first-ever billion dollars in sales amidst an unprecedented move by the Biden administration to support waiving patent rights for COVID-19 vaccines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.